Edge Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
SGA
Edge Asset Management's NVO Position: Q1 2017 in Review
Edge Asset Management increased its Novo Nordisk (NVO) stake by 31% in Q1 2017, buying an estimated $139K and bringing the position to 34,000 shares worth $583K. The position accounts for ﹤0.01% of the portfolio, ranked #261.
Edge Asset Management first reported a position in NVO in Q4 2013 and has held it in 14 quarters since. The position peaked at $623K in Q1 2016. 463 funds tracked by Wall St. Rank hold NVO as of Q1 2017.
- Edge Asset Management held 34,000 shares of Novo Nordisk worth $583K as of Q1 2017.
- Edge Asset Management bought 8,000 Novo Nordisk shares in Q1 2017, an estimated $139K.
- Novo Nordisk made up ﹤0.01% of Edge Asset Management's portfolio in Q1 2017, its #261 holding.
- Edge Asset Management first reported a position in Novo Nordisk in Q4 2013 and has held it in 14 quarters since.
- Edge Asset Management's Novo Nordisk position peaked at $623K in Q1 2016.
- 463 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2017.
Based on Edge Asset Management's 13F filing for Q1 2017, filed 11 May 2017.